Documentation Centre

 

 

  of 18 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Oxidized low-density lipoprotein in inflammation-driven thrombosis. J Thromb Haemost. 2018;16:418-428 June 11, 2018 Oxidized low-density lipoprotein in inflammation-driven thrombosis. J Thromb Haemost. 2018;16:418-428 Obermayer G, Afonyushkin T, Binder CJ Key Publications
Risk assessment in patients with diabetes with the TIMI risk score for atherothrombotic disease. Diabetes Care. 2018;41:577-585 June 01, 2018 Risk assessment in patients with diabetes with the TIMI risk score for atherothrombotic disease. Diabetes Care. 2018;41:577-585 Bergmark BA, Bhatt DL, Braunwald E, Morrow DA, Steg PG, Gurmu Y, Cahn A, Mosenzon O, Raz I, Bohula E, Scirica BM Key Publications
Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study. Coron Artery Dis. 2017;28:577-587 January 19, 2018 Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study. Coron Artery Dis. 2017;28:577-587 Iida K, Tani S, Atsumi W, Yagi T, Kawauchi K, Matsumoto N, Hirayama A Key Publications
Mechanisms of erosion of atherosclerotic plaques. Curr Opin Lipidol. 2017;28:434-441 November 20, 2017 Mechanisms of erosion of atherosclerotic plaques. Curr Opin Lipidol. 2017;28:434-441 Quillard T, Franck G, Mawson T, Folco E, Libby P. Key Publications
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest. 2017;127:83-93 May 10, 2017 Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk. J Clin Invest. 2017;127:83-93 Goldfine AB, Shoelson SE Key Publications
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease. Am Heart J. 2016;181:92-100 February 08, 2017 A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart disease. Am Heart J. 2016;181:92-100 Welsh RC, Roe MT, Steg PG, James S, Povsic TJ, Bode C, Gibson CM, Ohman EM Key Publications
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. Int J Cardiol 2013;167:2904-11 December 20, 2013 Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. Int J Cardiol 2013;167:2904-11 Lyngbæk S, Marott JL, Sehestedt T, Hansen TW, Olsen MH, Andersen O, Linneberg A, Haugaard SB, Eugen-Olsen J, Hansen PR, Jeppesen J. Key Publications
Effects of a single bout of walking exercise on blood coagulation parameters in obese women. J Appl Physiol 2013;115:57-63 September 24, 2013 Effects of a single bout of walking exercise on blood coagulation parameters in obese women. J Appl Physiol 2013;115:57-63 Lamprecht M, Moussalli H, Ledinski G, Leschnik B, Schlagenhauf A, Koestenberger M, Polt G, Cvirn G. Key Publications
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20 December 06, 2012 C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20 Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E et al. Key Publications
Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery. Nutr Metab Cardiovasc Dis 2012;22:340-6 June 28, 2012 Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery. Nutr Metab Cardiovasc Dis 2012;22:340-6 Tschoner A, Sturm W, Engl J, Kaser S, Laimer M, Laimer E, Klaus A, Patsch JR, Ebenbichler CF. Key Publications

  of 18 Next page

Go to page: of